請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/34975
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 黃德富 | |
dc.contributor.author | Ling-Ju Chang | en |
dc.contributor.author | 張齡如 | zh_TW |
dc.date.accessioned | 2021-06-13T06:37:58Z | - |
dc.date.available | 2005-08-04 | |
dc.date.copyright | 2005-08-04 | |
dc.date.issued | 2005 | |
dc.date.submitted | 2005-07-27 | |
dc.identifier.citation | Adams, J.C. and Watt, F.M. (1990) Changes in keratinocyte adhesion during terminal differentiation: reduction in fibronectin binding precedes alpha 5 beta 1 integrin loss from the cell surface. Cell, 63, 425-435.
Albelda, S.M. (1993) Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest, 68, 4-17. Arnould, T., Michiels, C., Janssens, D., Delaive, E. and Remacle, J. (1995) Hypoxia induces PMN adherence to umbilical vein endothelium. Cardiovasc Res, 30, 1009-1016. Beasley, N.J., Leek, R., Alam, M., Turley, H., Cox, G.J., Gatter, K., Millard, P., Fuggle, S. and Harris, A.L. (2002) Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res, 62, 2493-2497. Bedogni, B., O'Neill, M.S., Welford, S.M., Bouley, D.M., Giaccia, A.J., Denko, N.C. and Powell, M.B. (2004) Topical treatment with inhibitors of the phosphatidylinositol 3'-kinase/Akt and Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways reduces melanoma development in severe combined immunodeficient mice. Cancer Res, 64, 2552-2560. Beierle, E.A., Strande, L.F., Berger, A.C. and Chen, M.K. (2001) VEGF is upregulated in a neuroblastoma and hepatocyte coculture model. J Surg Res, 97, 34-40. Beierle, E.A., Dai, W., Langham, M.R., Jr., Copeland, E.M., 3rd and Chen, M.K. (2004) Expression of VEGF receptors in cocultured neuroblastoma cells. J Surg Res, 119, 56-65. Bequet-Romero, M. and Lopez-Ocejo, O. (2000) Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins. Biochem Biophys Res Commun, 277, 55-61. Berra, E., Pages, G. and Pouyssegur, J. (2000) MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev, 19, 139-145. Berwick, M. and Halpern, A. (1997) Melanoma epidemiology. Curr Opin Oncol, 9, 178-182. Bikfalvi, A., Klein, S., Pintucci, G. and Rifkin, D.B. (1997) Biological roles of fibroblast growth factor-2. Endocr Rev, 18, 26-45. Blaschke, F., Stawowy, P., Goetze, S., Hintz, O., Grafe, M., Kintscher, U., Fleck, E. and Graf, K. (2002) Hypoxia activates beta(1)-integrin via ERK 1/2 and p38 MAP kinase in human vascular smooth muscle cells. Biochem Biophys Res Commun, 296, 890-896. Blouw, B., Song, H., Tihan, T., Bosze, J., Ferrara, N., Gerber, H.P., Johnson, R.S. and Bergers, G. (2003) The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell, 4, 133-146. Bochner, B.H., Cote, R.J., Weidner, N., Groshen, S., Chen, S.C., Skinner, D.G. and Nichols, P.W. (1995) Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst, 87, 1603-1612. Borgstrom, P., Hillan, K.J., Sriramarao, P. and Ferrara, N. (1996) Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res, 56, 4032-4039. Brooks, P.C., Stromblad, S., Sanders, L.C., von Schalscha, T.L., Aimes, R.T., Stetler-Stevenson, W.G., Quigley, J.P. and Cheresh, D.A. (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell, 85, 683-693. Brown, J.M. and Wilson, W.R. (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer, 4, 437-447. Bruick, R.K. and McKnight, S.L. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 294, 1337-1340. Carlsen, N.L. (1990) How frequent is spontaneous remission of neuroblastomas? Implications for screening. Br J Cancer, 61, 441-446. Carmeliet, P., Dor, Y., Herbert, J.M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C.J., Ratcliffe, P., Moons, L., Jain, R.K., Collen, D. and Keshert, E. (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature, 394, 485-490. Chaplin, D.J., Olive, P.L. and Durand, R.E. (1987) Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res, 47, 597-601. Chung, J., Yoon, S., Datta, K., Bachelder, R.E. and Mercurio, A.M. (2004) Hypoxia-induced vascular endothelial growth factor transcription and protection from apoptosis are dependent on alpha6beta1 integrin in breast carcinoma cells. Cancer Res, 64, 4711-4716. Clark, E.A. and Brugge, J.S. (1995) Integrins and signal transduction pathways: the road taken. Science, 268, 233-239. Danielsen, T. and Rofstad, E.K. (2000) The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts. Br J Cancer, 82, 1528-1534. Das, M., Bouchey, D.M., Moore, M.J., Hopkins, D.C., Nemenoff, R.A. and Stenmark, K.R. (2001) Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on g protein-mediated activation of mitogen-activated protein kinases. J Biol Chem, 276, 15631-15640. Ellerbroek, S.M., Fishman, D.A., Kearns, A.S., Bafetti, L.M. and Stack, M.S. (1999) Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. Cancer Res, 59, 1635-1641. Erhard, H., Rietveld, F.J., van Altena, M.C., Brocker, E.B., Ruiter, D.J. and de Waal, R.M. (1997) Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis. Melanoma Res, 7 Suppl 2, S19-26. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Powell-Braxton, L., Hillan, K.J. and Moore, M.W. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380, 439-442. Ferrara, N. and Davis-Smyth, T. (1997) The biology of vascular endothelial growth factor. Endocr Rev, 18, 4-25. Folkman, J. (1992) The role of angiogenesis in tumor growth. Semin Cancer Biol, 3, 65-71. Folkman, J. (1996) Tumor angiogenesis and tissue factor. Nat Med, 2, 167-168. Folkman, J. and Klagsbrun, M. (1987) Angiogenic factors. Science, 235, 442-447. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D. and Semenza, G.L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol, 16, 4604-4613. Gille, J. and Swerlick, R.A. (1996) Integrins: role in cell adhesion and communication. Ann N Y Acad Sci, 797, 93-106. Ginis, I., Mentzer, S.J., Li, X. and Faller, D.V. (1995) Characterization of a hypoxia-responsive adhesion molecule for leukocytes on human endothelial cells. J Immunol, 155, 802-810. Graells, J., Vinyals, A., Figueras, A., Llorens, A., Moreno, A., Marcoval, J., Gonzalez, F.J. and Fabra, A. (2004) Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling. J Invest Dermatol, 123, 1151-1161. Graeven, U., Rodeck, U., Karpinski, S., Jost, M., Philippou, S. and Schmiegel, W. (2001) Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor. Cancer Res, 61, 7282-7290. Guidi, A.J., Abu-Jawdeh, G., Berse, B., Jackman, R.W., Tognazzi, K., Dvorak, H.F. and Brown, L.F. (1995) Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst, 87, 1237-1245. Haas, D., Ablin, A.R., Miller, C., Zoger, S. and Matthay, K.K. (1988) Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer, 62, 818-825. Hasan, N.M., Parker, P.J. and Adams, G.E. (1996) Induction and phosphorylation of protein kinase C-alpha and mitogen-activated protein kinase by hypoxia and by radiation in Chinese hamster V79 cells. Radiat Res, 145, 128-133. Hazlehurst, L.A., Valkov, N., Wisner, L., Storey, J.A., Boulware, D., Sullivan, D.M. and Dalton, W.S. (2001) Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells. Blood, 98, 1897-1903. Hewett, P.W. (2001) Identification of tumour-induced changes in endothelial cell surface protein expression: an in vitro model. Int J Biochem Cell Biol, 33, 325-335. Hill, R.P. (1990) Tumor progression: potential role of unstable genomic changes. Cancer Metastasis Rev, 9, 137-147. Hlatky, L., Tsionou, C., Hahnfeldt, P. and Coleman, C.N. (1994) Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res, 54, 6083-6086. Houghton, A.N. and Polsky, D. (2002) Focus on melanoma. Cancer Cell, 2, 275-278. Hynes, R.O. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69, 11-25. Hynes, R.O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell, 110, 673-687. Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J.M., Lane, W.S. and Kaelin, W.G., Jr. (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science, 292, 464-468. Jaakkola, P., Mole, D.R., Tian, Y.M., Wilson, M.I., Gielbert, J., Gaskell, S.J., Kriegsheim, A., Hebestreit, H.F., Mukherji, M., Schofield, C.J., Maxwell, P.H., Pugh, C.W. and Ratcliffe, P.J. (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science, 292, 468-472. Janet, T., Ludecke, G., Otten, U. and Unsicker, K. (1995) Heterogeneity of human neuroblastoma cell lines in their proliferative responses to basic FGF, NGF, and EGF: correlation with expression of growth factors and growth factor receptors. J Neurosci Res, 40, 707-715. Juliano, R.L. (1987) Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochim Biophys Acta, 907, 261-278. Juliano, R.L. and Haskill, S. (1993) Signal transduction from the extracellular matrix. J Cell Biol, 120, 577-585. Kallman, R.F. (1972) The phenomenon of reoxygenation and its implications for fractionated radiotherapy. Radiology, 105, 135-142. Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N.A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J. and et al. (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet, 8, 23-26. Keegan, K., Johnson, D.E., Williams, L.T. and Hayman, M.J. (1991) Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci U S A, 88, 1095-1099. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature, 362, 841-844. Kim, S., Bakre, M., Yin, H. and Varner, J.A. (2002) Inhibition of endothelial cell survival and angiogenesis by protein kinase A. J Clin Invest, 110, 933-941. Kim, S., Bell, K., Mousa, S.A. and Varner, J.A. (2000) Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol, 156, 1345-1362. Klagsbrun, M. and D'Amore, P.A. (1991) Regulators of angiogenesis. Annu Rev Physiol, 53, 217-239. Klein, C.L., Kohler, H., Bittinger, F., Otto, M., Hermanns, I. and Kirkpatrick, C.J. (1995) Comparative studies on vascular endothelium in vitro. 2. Hypoxia: its influences on endothelial cell proliferation and expression of cell adhesion molecules. Pathobiology, 63, 1-8. Kon, S., Yokosaki, Y., Maeda, M., Segawa, T., Horikoshi, Y., Tsukagoshi, H., Rashid, M.M., Morimoto, J., Inobe, M., Shijubo, N., Chambers, A.F. and Uede, T. (2002) Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences. J Cell Biochem, 84, 420-432. Kondo, K., Klco, J., Nakamura, E., Lechpammer, M. and Kaelin, W.G., Jr. (2002) Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell, 1, 237-246. Kroon, M.E., Koolwijk, P., van der Vecht, B. and van Hinsbergh, V.W. (2001) Hypoxia in combination with FGF-2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: involvement of at least two signal transduction pathways. J Cell Sci, 114, 825-833. Kung, A.L., Wang, S., Klco, J.M., Kaelin, W.G. and Livingston, D.M. (2000) Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med, 6, 1335-1340. Kunz, M., Moeller, S., Koczan, D., Lorenz, P., Wenger, R.H., Glocker, M.O., Thiesen, H.J., Gross, G. and Ibrahim, S.M. (2003) Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J Biol Chem, 278, 45651-45660. Laderoute, K.R., Mendonca, H.L., Calaoagan, J.M., Knapp, A.M., Giaccia, A.J. and Stork, P.J. (1999) Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity. J Biol Chem, 274, 12890-12897. Li, A., Li, H., Zhang, J., Jin, G. and Xiu, R. (2003) The mitogenic and anti-apoptotic activity of tumor conditioned medium on endothelium. Clin Hemorheol Microcirc, 29, 375-382. Liu, Y., Cox, S.R., Morita, T. and Kourembanas, S. (1995) Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res, 77, 638-643. Ludecke, G. and Unsicker, K. (1990) Mitogenic effect of neurotrophic factors on human IMR 32 neuroblastoma cells. Cancer, 65, 2270-2278. Macchiarini, P., Fontanini, G., Hardin, M.J., Squartini, F. and Angeletti, C.A. (1992) Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet, 340, 145-146. Maeda, K., Chung, Y.S., Ogawa, Y., Takatsuka, S., Kang, S.M., Ogawa, M., Sawada, T. and Sowa, M. (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer, 77, 858-863. Marcoval, J., Moreno, A., Graells, J., Vidal, A., Escriba, J.M., Garcia-Ramirez, M. and Fabra, A. (1997) Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase. J Cutan Pathol, 24, 212-218. Mattern, J., Koomagi, R. and Volm, M. (1996) Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer, 73, 931-934. Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.C., Cockman, M.E., Wykoff, C.C., Pugh, C.W., Maher, E.R. and Ratcliffe, P.J. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399, 271-275. McEwen, A., Emmanuel, C., Medbury, H., Leick, A., Walker, D.M. and Zoellner, H. (2003) Induction of contact-dependent endothelial apoptosis by osteosarcoma cells suggests a role for endothelial cell apoptosis in blood-borne metastasis. J Pathol, 201, 395-403. Milas, L., Hirata, H., Hunter, N. and Peters, L.J. (1988) Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas. Cancer Res, 48, 2116-2120. Moscatelli, D., Presta, M. and Rifkin, D.B. (1986) Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. Proc Natl Acad Sci U S A, 83, 2091-2095. Mustonen, T. and Alitalo, K. (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol, 129, 895-898. Nathanson, S.D., Westrick, P., Anaya, P., Hetzel, F.W. and Jacobsen, G. (1989) Relationship of spontaneous regional lymph node metastases to dose of local irradiation of primary B16 melanomas. Cancer Res, 49, 4412-4416. Oku, T., Tjuvajev, J.G., Miyagawa, T., Sasajima, T., Joshi, A., Joshi, R., Finn, R., Claffey, K.P. and Blasberg, R.G. (1998) Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts. Cancer Res, 58, 4185-4192. Oliveria, S., Dusza, S. and Berwick, M. (2001) Issues in the epidemiology of melanoma. Expert Rev Anticancer Ther, 1, 453-459. Onoda, J.M., Piechocki, M.P. and Honn, K.V. (1992) Radiation-induced increase in expression of the alpha IIb beta 3 integrin in melanoma cells: effects on metastatic potential. Radiat Res, 130, 281-288. Park, J.E., Keller, G.A. and Ferrara, N. (1993) The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell, 4, 1317-1326. Parkin, D.M., Laara, E. and Muir, C.S. (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer, 41, 184-197. Partanen, J., Makela, T.P., Eerola, E., Korhonen, J., Hirvonen, H., Claesson-Welsh, L. and Alitalo, K. (1991) FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. Embo J, 10, 1347-1354. Pasqualini, R., Koivunen, E. and Ruoslahti, E. (1995) A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J Cell Biol, 130, 1189-1196. Pepper, M.S., Ferrara, N., Orci, L. and Montesano, R. (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun, 189, 824-831. Pietersma, A., de Jong, N., Koster, J.F. and Sluiter, W. (1994) Extreme hypoxia decreases the adherence of granulocytes to endothelial cells in vitro. Ann N Y Acad Sci, 723, 486-487. Pritchard, J. and Hickman, J.A. (1994) Why does stage 4s neuroblastoma regress spontaneously? Lancet, 344, 869-870. Pugh, C.W. and Ratcliffe, P.J. (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med, 9, 677-684. Ramsay, J., Suit, H.D. and Sedlacek, R. (1988) Experimental studies on the incidence of metastases after failure of radiation treatment and the effect of salvage surgery. Int J Radiat Oncol Biol Phys, 14, 1165-1168. Risau, W. (1997) Mechanisms of angiogenesis. Nature, 386, 671-674. Roberts, W.G. and Palade, G.E. (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci, 108 (Pt 6), 2369-2379. Rofstad, E.K. and Danielsen, T. (1999) Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis. Br J Cancer, 80, 1697-1707. Rogelj, S., Klagsbrun, M., Atzmon, R., Kurokawa, M., Haimovitz, A., Fuks, Z. and Vlodavsky, I. (1989) Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells. J Cell Biol, 109, 823-831. Ruoslahti, E. and Pierschbacher, M.D. (1987) New perspectives in cell adhesion: RGD and integrins. Science, 238, 491-497. Ryan, H.E., Lo, J. and Johnson, R.S. (1998) HIF-1 alpha is required for solid tumor formation and embryonic vascularization. Embo J, 17, 3005-3015. Ryan, H.E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J.M. and Johnson, R.S. (2000) Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res, 60, 4010-4015. Saida, T. (2001) Recent advances in melanoma research. J Dermatol Sci, 26, 1-13. Saleh, M., Stacker, S.A. and Wilks, A.F. (1996) Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res, 56, 393-401. Salven, P., Heikkila, P. and Joensuu, H. (1997) Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer, 76, 930-934. Schwickert, G., Walenta, S., Sundfor, K., Rofstad, E.K. and Mueller-Klieser, W. (1995) Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res, 55, 4757-4759. Seftor, R.E. (1998) Role of the beta3 integrin subunit in human primary melanoma progression: multifunctional activities associated with alpha(v)beta3 integrin expression. Am J Pathol, 153, 1347-1351. Seftor, R.E., Seftor, E.A. and Hendrix, M.J. (1999) Molecular role(s) for integrins in human melanoma invasion. Cancer Metastasis Rev, 18, 359-375. Seko, Y., Tobe, K., Ueki, K., Kadowaki, T. and Yazaki, Y. (1996) Hypoxia and hypoxia/reoxygenation activate Raf-1, mitogen-activated protein kinase kinase, mitogen-activated protein kinases, and S6 kinase in cultured rat cardiac myocytes. Circ Res, 78, 82-90. Semenza, G.L. (2001) Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatr Res, 49, 614-617. Semenza, G.L. (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3, 721-732. Senger, D.R., Van de Water, L., Brown, L.F., Nagy, J.A., Yeo, K.T., Yeo, T.K., Berse, B., Jackman, R.W., Dvorak, A.M. and Dvorak, H.F. (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev, 12, 303-324. Shalaby, F., Ho, J., Stanford, W.L., Fischer, K.D., Schuh, A.C., Schwartz, L., Bernstein, A. and Rossant, J. (1997) A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell, 89, 981-990. Shellman, Y.G., Park, Y.L., Marr, D.G., Casper, K., Xu, Y., Fujita, M., Swerlick, R. and Norris, D.A. (2003) Release of vascular endothelial growth factor from a human melanoma cell line, WM35, is induced by hypoxia but not ultraviolet radiation and is potentiated by activated Ras mutation. J Invest Dermatol, 121, 910-917. Shemirani, B. and Crowe, D.L. (2000) Head and neck squamous cell carcinoma lines produce biologically active angiogenic factors. Oral Oncol, 36, 61-66. Shibaji, T., Nagao, M., Ikeda, N., Kanehiro, H., Hisanaga, M., Ko, S., Fukumoto, A. and Nakajima, Y. (2003) Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer. Anticancer Res, 23, 4721-4727. Shih, I.M. and Herlyn, M. (1994) Autocrine and paracrine roles for growth factors in melanoma. In Vivo, 8, 113-123. Takahashi, Y., Kitadai, Y., Bucana, C.D., Cleary, K.R. and Ellis, L.M. (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res, 55, 3964-3968. Tan, C., de Noronha, R.G., Roecker, A.J., Pyrzynska, B., Khwaja, F., Zhang, Z., Zhang, H., Teng, Q., Nicholson, A.C., Giannakakou, P., Zhou, W., Olson, J.J., Pereira, M.M., Nicolaou, K.C. and Van Meir, E.G. (2005) Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res, 65, 605-612. Tang, N., Wang, L., Esko, J., Giordano, F.J., Huang, Y., Gerber, H.P., Ferrara, N. and Johnson, R.S. (2004) Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell, 6, 485-495. Toi, M., Inada, K., Hoshina, S., Suzuki, H., Kondo, S. and Tominaga, T. (1995) Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res, 1, 961-964. Troussard, A.A., Costello, P., Yoganathan, T.N., Kumagai, S., Roskelley, C.D. and Dedhar, S. (2000) The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene, 19, 5444-5452. Vartanian, R.K. and Weidner, N. (1994) Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol, 144, 1188-1194. Volm, M. and Koomagi, R. (2000) Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res, 20, 1527-1533. Walton, H.L., Corjay, M.H., Mohamed, S.N., Mousa, S.A., Santomenna, L.D. and Reilly, T.M. (2000) Hypoxia induces differential expression of the integrin receptors alpha(vbeta3) and alpha(vbeta5) in cultured human endothelial cells. J Cell Biochem, 78, 674-680. Wang, G.L., Jiang, B.H., Rue, E.A. and Semenza, G.L. (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A, 92, 5510-5514. Weidner, N. (1993) Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol, 10, 302-313. Weidner, N., Semple, J.P., Welch, W.R. and Folkman, J. (1991) Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med, 324, 1-8. Yamamoto, K. and Yamamoto, M. (1994) Cell adhesion receptors for native and denatured type I collagens and fibronectin in rabbit arterial smooth muscle cells in culture. Exp Cell Res, 214, 258-263. Yokosaki, Y., Matsuura, N., Higashiyama, S., Murakami, I., Obara, M., Yamakido, M., Shigeto, N., Chen, J. and Sheppard, D. (1998) Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C. J Biol Chem, 273, 11423-11428. Young, S.D. and Hill, R.P. (1990) Effects of reoxygenation on cells from hypoxic regions of solid tumors: analysis of transplanted murine tumors for evidence of DNA overreplication. Cancer Res, 50, 5031-5038. Young, S.D., Marshall, R.S. and Hill, R.P. (1988) Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A, 85, 9533-9537. Zagzag, D. (1995) Angiogenic growth factors in neural embryogenesis and neoplasia. Am J Pathol, 146, 293-309. Zgouras, D., Wachtershauser, A., Frings, D. and Stein, J. (2003) Butyrate impairs intestinal tumor cell-induced angiogenesis by inhibiting HIF-1alpha nuclear translocation. Biochem Biophys Res Commun, 300, 832-838. Zhang, H.T., Craft, P., Scott, P.A., Ziche, M., Weich, H.A., Harris, A.L. and Bicknell, R. (1995) Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst, 87, 213-219. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M.M., Simons, J.W. and Semenza, G.L. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res, 60, 1541-1545. Zhong, H., De Marzo, A.M., Laughner, E., Lim, M., Hilton, D.A., Zagzag, D., Buechler, P., Isaacs, W.B., Semenza, G.L. and Simons, J.W. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res, 59, 5830-5835. Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A.R., Ryan, H.E., Johnson, R.S., Jefferson, A.B., Stokoe, D. and Giaccia, A.J. (2000) Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev, 14, 391-396. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/34975 | - |
dc.description.abstract | 血管新生對於固態腫瘤的生長及轉移過程中是必要的。很多生長因子包括血管內皮生長因子(VEGF)、鹼性纖維母細胞生長因(bFGF)、腫瘤壞死因子-α (TNF-α),上皮生長因子(EGF)是強的血管新生誘導劑,能促進血管內皮細胞的增生及移行。在很多的固態腫瘤中,這些血管因子是與高血管密度、淋巴節的轉移與不好的預後相關。處在低氧環境的腫瘤細胞會增加VEGF的表現。本篇研究的目的是想探討由低氧引起腫瘤細胞釋放之conditioned medium (CM)的可溶物質是否會促進血管新生。本文所探討的腫瘤包括小鼠黑色素腫瘤細胞及自發性神經母細胞瘤。與正常氧壓組相比,加入從低氧腫瘤細胞取得的CM,可促進HUVEC增生。當在低氧B16F10細胞取得的CM中加入neutralizing VEGF抗體後,這個促進增生的作用會被抑制。但在Neuro-2A細胞組,低氧與正常情況下都會被VEGF抗體所抑制。我們也發現低氧能促進B16F10細胞釋放VEGF。因此我們認為由低氧誘導之VEGF表現增加能促進內皮細胞的增生。接下來我們想探討低氧對於B16F10和Neuro-2A細胞表面integrin受體之表現及其附著在細胞外基質的作用為何。結果發現處在低氧下的B16F10細胞能增加β1 integrin的表現,而進一步增加對於fibronectin的附著,但對於collagen type I的附著卻是減少的。另外從流式細胞儀分析,低氧不會促進αv和β3 integrin的表現,但從附著實驗中,卻看到低氧會促進B16F10細胞對vitronectin的附著。另一方面,我們沒有觀察到低氧改變Neuro-2A細胞表面的integrin表現的作用。我們也利用基因微陣列分析來廣泛觀察低氧對B16F10細胞基因表現的影響,並藉由這個工具來驗證上述結果。這些結果顯示低氧可能藉由與β1有關的integrin來改變B16F10細胞對不同細胞外基質的附著。至於是哪些特定的integrin、調控腫瘤細胞附著及其他與腫瘤進程有關之行為的機轉仍有待進一步的研究。 | zh_TW |
dc.description.abstract | Previous studies have shown that angiogenesis is required for growth and metastasis of solid tumors. Many growth factors including vascular endothelial growth factors (VEGFs), basic fibroblast growth factor (bFGF), tumor necrosis factor-α (TNF-α) and epidermal growth factor (EGF) are potent angiogenesis inducers through stimulating the proliferation and migration of capillary endothelial cells. In many solid tumors, expression of these factors correlates with high vascularity, lymph node metastasis, and poor clinical prognosis. Tumor cells exposed to hypoxia have been shown to up-regulate the expression of VEGF. The purpose of the present study was to investigate whether hypoxia-induced upregulation of soluble mediators that are released into tumor cell conditioned medium (CM) can result in an induction of angiogenesis. The tumors studied were Neuro-2A neuroblastoma from strain A albino mice and B16F10 melanoma from C57BL/6J mice. A significant increase in cell proliferation was seen at 48 hr when HUVEC were cultured with the CM from hypoxic tumor cells as compared with normoxic counterpart. This increased proliferation was abrogated by preincubation of neutralizing VEGF antibodies with CM from hypoxic B16F10 cells. However, for Neuro-2A cells cultured under hypoxic and normoxic conditions, the increase of HUVEC proliferation was inhibited by adding neutralizing VEGF antibodies to both CMs. We also detected that hypoxia enhanced VEGF release from B16F10 cells. Therefore, we suggest that the increased production of VEGF induced by hypoxia stimulates endothelial cell proliferation. The effects of hypoxia on integrin expression and adhesion to extracellular matrix (ECM) proteins were investigated. Exposure of B16F10 cells to hypoxia caused a significant upregulation of β1 integrin and an associated increase in cell adhesion to fibronectin, but intriguingly, a decrease in adhesion to collagen type I. Through flow cytometric analysis, we did not find any prominent upregulation of αv and β3 integrin expression on B16F10 cell surface under hypoxic condition. However, we found an increase in cell adhesion to vitronectin. On the other hand, we did not find any significant alteration of integrin expression of Neuro-2A cells under hypoxic condition. Using microarray analysis, we also extensively observed the effect of hypoxia on the gene expression level of B16f10 cells and use this tool to confirm the above results. These results demonstrate that hypoxia may alter adhesion properties of B16F10 cells to ECM proteins through the interaction of β1–associated integrin(s). However, the identity of the specific integrin and its mechanism of regulating B16F10
cell adhesion to ECM or other behaviors related to tumor progression still need to be investigated. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T06:37:58Z (GMT). No. of bitstreams: 1 ntu-94-R92443004-1.pdf: 1561975 bytes, checksum: 8a840bc506d2576422c76d86732e656b (MD5) Previous issue date: 2005 | en |
dc.description.tableofcontents | 1. 縮寫表………………………………………………… 1
2. 中文摘要……………………………………………… 3 3. 英文摘要 ……………………………………………… 5 4. 緒論 …………………………………………………… 7 5. 實驗材料和方法 ……………………………………… 21 6. 實驗結果 ……………………………………………… 29 7. 結果圖表……………………………………………… 36 8. 討論…………………………………………………… 51 9. 參考資料……………………………………………… 61 | |
dc.language.iso | zh-TW | |
dc.title | 低氧對腫瘤細胞引起的血管新生及對其表面粘著分子表現之改變及效應 | zh_TW |
dc.title | The Alteration of Tumor Cell Induced Angiogenesis and its Surface Adhesion Molecules Expression Caused by Hypoxia and their Effects | en |
dc.type | Thesis | |
dc.date.schoolyear | 94-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 鄧哲明,顏茂雄,楊春茂,王寧 | |
dc.subject.keyword | 低氧,生長因子,腫瘤細胞,integrin, | zh_TW |
dc.subject.keyword | hypoxia,integrin,growth factor,tumor cell, | en |
dc.relation.page | 72 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2005-07-27 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-94-1.pdf 目前未授權公開取用 | 1.53 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。